DHEA Against Vaginal Atrophy - 3-Month Efficacy Study

Completed · Phase 3 · Has a placebo group

Conditions studied: Vaginal Atrophy

In brief

The purpose of this Phase III trial is to confirm the efficacy of intravaginal dehydroepiandrosterone (DHEA) in postmenopausal women with vaginal atrophy.

Key facts

Study ID
NCT01256684
Run by
EndoCeutics Inc.
People needed
255
Starts
2010-12-01
Expected to finish
2011-11-01
Last updated by the study team
2017-06-26

Who can join

Age: 40 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.